Aortic cross - clamp duration in cardiopulmonary bypass oxidative stress relationship

The aim of this study was to determine whether there is a direct correlation between the aortic cross-clamp (ACC) duration and oxidative stress marker levels in systemic blood of patients undergoing CPB (cardiopulmonary bypass). We have evaluated the changes in oxidant-antioxidant balance and its relation to ACC time by measuring PON1, ARE, TOS and TAS. The ACC duration mean of 70 patients (43 males, 27 females) to whom CPB was made was 37 minutes. We divided the patients into two groups since their ACC duration was below and above 37 minutes. The HDL (high-density lipoprotein) and levels of TAS, TOS, PON1 and ARE; the oxidative stress markers, were analyzed by taking blood from the patients in the first hour before the pump and after the pump. The levels of oxidative stress markers, PON1, ARE, TOS and TAS were MEASURED within 1 hour before the pump and after the pump. While the serum TOS levels were 4.59±5.32 as preoperative and 4.01±4.34 as postoperative in Group I (ACC over 37 minutes), they were found 4.28±5.54 as preoperative and 2.02±2.57 as postoperative in Group II and determined as a statistically significant decrease (p

PDF

___

Wysocka Anna, A,Cybulski M, Berbec H, et al. Dynamic changes of paraoxonase 1 activity towards paroxon and phenyl acetate during coronary artery surgery. BMC Cardiovascular Disorders.2017;17:92.

Wysocka A, Cybulski M, Berbeć H, et al. Prognostic value of paraoxonase 1 in patients undergoing coronary artery bypass grafting surgery. Med Sci Monit. 2014;20:594-600.

Luyten CR, Overveld FJV, Backer LAD et al. Antioxidant defence during cardiopulmonary bypass surgery. Eur J Cardiothorac Surg. 2005;27:611-6.

Raedschelders K, Ansley DM, Chen DY. The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion. Pharmacol Ther. 2012;133:230-55.

van Himbergen TM, van der Schouw YT, Voorbij HAM, et al. Paraoxonase1 (PON1) and the risk for coronary heart disease and myocardial infarction in a general population of Dutch women. Atherosclerosis. 2008;198:408-14.

Ayub A, Mackness MI, Arrol S, et al. Serum paraoxonase after myocardial infarction. Arterioscler Thromb Vasc Biol. 1999;19:330–5.

Van Wagoner DR. Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J Cardiovasc Pharmacol. 2008;52:306-13.

Biglioli P, Cannata A, Alamanni F, et al. Biological effects of off-pump vs. on-pump coronary artery surgery: focus on inflammation, hemostasis and oxidative stress. Eur J Cardiothorac Surg. 2003;24:260-9.

Watson AD, Berliner JA, Hama SY, et al. Protective effect of high density lipoprotein associated paraoxanase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin In-vest. 1995;96:2882-91.

Cervellati C1, Bonaccorsi G2,3, Trentini A, et al. Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women. Scand J Clin Lab Invest. 2018;78:18-24.

Milei J, Grana DR, Forcada P, et al. Mitochondrial oxidative and structural damage in ischemia-reperfusion in human myocardium. Current knowledge and future directions. Front Biosci. 2007;12:1124-30.

Luyten CR, van Overveld FJ, de Backer LA, et al. Antioxidant defence during cardiopulmonary bypass surgery. Eur J Cardiothorac Surg. 2005;27:611-6.

Zhang PY, XU X, LI XC. Cardiovascular diseases: oxidative damage and antioxidant protection. Eur Rev Med Pharmacol Sci. 2014;18:3091-6.

Kunt AS, Selek S, Celik H, et al. Decrease of total antioxidant capacity during coronary artery bypass surgery. Mt Sinai J Med. 2006;73:777-83.

García-de-la-Asunción J, Pastor E, Perez-Griera J, et al. Oxidative stress injury after on-pump cardiac surgery: effects of aortic cross clamp time and type of surgery. Redox Rep. 2013;18:193-9.

Akila VP, D’souza B, Vishwanath P, et al. Oxidative injury and antioxidants in coronary artery bypass graft surgery: off-pump CABG significantly reduces oxidative stress. Clin Chim Acta. 2007;375:147–52.

Ulus AT, Aksoyek A, Ozkan M, et al. Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans. Free Rad Biol Med. 2003;34:911-7.

Ferrari R, Alfieri O, Curello S, et al. Occurrence of oxidative stress during reperfusion of the human heart. Circulation, 1990;81:201-11.

Nowicki R, Saczko J, Kulbacka J, et al. The estimation of oxidative stress markers and apoptosis in right atrium auricles cardiomyocytes of patients undergoing surgical heart revascularisation with the use of warm blood cardioplegia. Folia Histochem Cytobiol. 2010;48:202-7.

Milei J, Grana DR, Forcada P, et al. Mitochondrial oxidative and structural damage in ischemia-reperfusion in human myocardium. Current knowledge and future directions. Front Biosci. 2007;12:1124-30.

Milei J, Forcada P, Fraga CG, et al. Relationship between oxidative stress, lipid peroxidation, and ultrastructural damage in patients with coronary artery disease undergoing cardioplegic arrest/reperfusion. Cardiovasc Res. 2007;73:710-9.

Clermont G, Vergely C, Jazayeri S, et al. Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology. 2002;96:80-7.

Kevin LG, Novalija E, Stowe DF. Reactive oxygen species as mediators of cardiac injury and protection: the relevance to anaesthesia practice. Anesth Analg. 2005;101:1275-87.

Pantke U, Volk T, Schmutzler M, et al. Oxidized proteins as a marker of oxidative stress during coronary heart surgery. Free Rad Biol Med. 1999;9:10806.

Cavalca V, Sisillo E, Veglia F, et al. Isoprostanes and oxidative stress in offpump and on-pump coronary bypass surgery. Ann Thorac Surg. 2006;81:5627.

Leong JY, van der Merwe J, Pepe S, et al. Perioperative metabolic therapy improves redox status and outcomes in cardiac surgery patients: a randomised trial. Heart Lung Circ. 2010;19:584-91.

Papoulidis P, Ananiadou O, Chalvatzoulis E, Ampatzidou F, Koutsogiannidis C, Karaiskos T, et al. The role of ascorbic acid in the prevention of atrial f ibrillation after elective on-pump myocardial revascularization surgery: a single-center experience- a pilot study. Interact Cardiovasc Thorac Surg. 2011;12:121-4.

Yonem A, Duran C, Unal M, et al. Plasma apelin and asymmetric dimethylarginine levels in type 2 diabetic patients with diabetic retinopathy. Diabetes Res Clin Pract. 2009;84:219-23.